COSMO PHARMACEUTICALS N.V.

Insiders Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Market Closed - Swiss Exchange Other stock markets 11:30:02 2024-05-17 am EDT			5-day change	1st Jan Change
72.9 ^CHF	-0.82%		+1.67%	+43.22%

Apr. 26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
Apr. 25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	Apr. 26	CI
Cosmo Pharmaceuticals Names New CEO, Chairman	Apr. 25	MT
GI Genius™ named to FORTUNE 2022 “Change the World” list	22-10-12	EQ
Cosmo Pharmaceuticals N.V. Announces Executive Changes	21-12-30	CI
Cosmo Pharmaceuticals N.V. Appoints Alexis De Rosnay as Non-Executive Member of the Board of Directors	21-11-16	CI
Cosmo Pharmaceuticals N.V. Announces Resignation of Hans Christoph Tanner as A Non-Executive Board Member	21-05-10	CI
Cosmo Pharmaceuticals N.V. Announces Executive Changes	20-12-18	CI
Cosmo Pharmaceuticals Appoints H. Jurgen Lenz as New Chief Medical Officer	20-12-01	CI
Cosmo Pharmaceuticals N.V. Announces Senior Leadership Changes, Effective January 1, 2021	20-11-23	CI
Cosmo Pharmaceuticals N.V. Announces Executive Changes	20-07-01	CI
Cosmo Pharmaceuticals N.V. Announces Executive Changes	20-03-12	CI
Cosmo Pharmaceuticals Announces Executive Changes	20-02-24	CI
Cosmo Pharmaceuticals N.V. Announces Change of Chief Scientific Officer	19-11-26	CI
Cosmo Pharmaceuticals N.V. Appoints John Manieri as Head of Cosmo's Investor Relation Activities and Head of the Investment Committee as of July 1, 2017	17-06-01	CI
Cosmo Pharmaceuticals N.V. Announces Resignation of Friedrich Von Bohlen from Board	17-04-10	CI
Cosmo Pharmaceuticals S.p.A. Announces Board Changes	12-04-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW